With 350 million people designated as carriers of hepatitis B, and 170 million chronically infected with hepatitis C, new treatments are urgently needed.
|Original language||English (US)|
|Number of pages||5|
|Journal||Chemistry and Industry (London)|
|State||Published - 1999|
ASJC Scopus subject areas
- Chemistry (miscellaneous)